Piribo logo
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report which provides an overview of the clinical trials market in Russia.
“Clinical Trials Market in Russia”, available at http://tinyurl.com/
According to the report, the Russian clinical trials have enjoyed significant foreign investments and accounts for more than two-third of the total clinical trials across the world. Russia sponsored 201 clinical trials in 2008, followed by American sponsors who conducted 145 clinical trials during the year. The clinical trials conducted by Russia include various therapy areas such as oncology, cardiology and pulmonology. The country has large number of physicians willing to work as clinical research investigators in order to enhance their knowledge in their fields of specialisation and earn a subsidiary income.
Having recently invested US$ 3.4 billion to improve the utilisation of resources in the Russian clinical trials market, the government is taking vital steps to bring healthcare reforms, and to encourage the Russian drug makers to have well-laid plans for the development of innovative drugs to compete in the market at par with foreign players.
The 60-page report is the outcome of extensive research and thorough analysis. It covers the various market dynamics that play upon the performance of the Russian clinical trials market. Further, the report will help the client to assess the future outlook of the industry based on the government initiatives, regulatory framework and the growth pattern of the pharmaceutical industry.
“Clinical Trials Market in Russia” is available from Piribo. For further information, please visit:
http://www.piribo.com/
Piribo product ID: RCS00306
